Infliximab for Crohn's disease: more questions than answers.
Freeman
H J
HJ
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D002170:Canada; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology*; D005765:Gastrointestinal Agents / Q000276:immunology* / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab